To analyze the efficacy of Infrared theraphy in treating dry eye due to meibomian gland dysfunction.

A clinical study on efficacy of infrared therapy in treating Chronic meibomian gland dysfunction - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/083952

Enrollment

100

Registered

2025-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H028- Other specified disorders of eyelid

Interventions

Intervention1: Infrared theraphy: Patients with chronic meibomian gland dysfunction will be treated with infrared warm compression device - 15 minutes on alternate days for 2weeks in addition to to

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with moderate to severe chronic mebomian gland dysfunction.

Exclusion criteria

Exclusion criteria: Patients not given consent Infectious conjunctivitis Allergic conjunctivitis Age group less than 18 years Hyposecretory dry eye

Design outcomes

Secondary

Measure	Time frame
Rate of recurrence after stoppage of theraphy.Timepoint: 2 weeks	—

Primary

Measure	Time frame
Decrease in symptoms and signs with decrease in clinical grade of Chronic meibomian gland dysfunctionTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDR Shalini M

Hassan institute of medical sciences

shalinimahadev99@gmail.com8310523949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026